Hikma Pharmaceutical | HIK - Sales Revenues

Stock Price
1,539.00
Daily Change
-13.00 -0.84%
Monthly
-1.79%
Yearly
-32.62%
Q1 Forecast
1,498.57

Hikma Pharmaceutical reported $829M in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Almirall EUR 560.46M 71.95M Jun/2025
argenx SE USD 987.09M 144.59M Sep/2025
AstraZeneca USD 15.19B 733M Sep/2025
Autolus Therapeutics Ltd USD 22.61M 1.71M Sep/2025
Bayer EUR 9.66B 1.08B Sep/2025
Fresenius EUR 5.48B 100M Sep/2025
Galapagos EUR 65.3M 4.87M Sep/2025
Genmab DKK 5.86B 580M Jun/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GRIFOLS EUR 1.87B 20M Sep/2025
Hikma Pharmaceutical USD 829M 758M Jun/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.32B 890M Sep/2025
Orion EUR 423.2M 6.7M Sep/2025
Recordati EUR 624.35M 18.8M Sep/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
UCB EUR 3.49B 129M Jun/2025